1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Anna Hearps
Our people

Dr Anna Hearps

Deputy Program Director, Disease Elimination; Head, Infection, Inflammation and Innate Immunity Group

Taking students

Working groups

annah@burnet.edu.au
Dr Anna Hearps

Reports and other work

Burnet publications

View 89 more
15 Mar 2025

Afucosylated broadly neutralising antibodies targeting HIV envelope elicit enhanced NK cell-mediated cytotoxicity against HIV-infected CD4+ T cell and macrophage targets

Journal of Leukocyte Biology

Morgane M. Brunton-O’Sullivan, Olaf G. Wilhelm, Christine Jordan, Hans Kek, Laura Rikard-Bell, Pantelis Poumbourios, Bruce D. Wines, Anthony Jaworowski, Anna C. Hearps, Hans Kek

15 Mar 2025

Afucosylated broadly neutralising antibodies targeting HIV envelope elicit enhanced NK cell-mediated cytotoxicity against HIV-infected CD4+ T cell and macrophage targets

Journal of Leukocyte Biology

Morgane M. Brunton-O’Sullivan, Olaf G. Wilhelm, Christine Jordan, Hans Kek, Laura Rikard-Bell, Pantelis Poumbourios, Bruce D. Wines, Anthony Jaworowski, Anna C. Hearps, Hans Kek

15 Mar 2025

Afucosylated broadly neutralising antibodies targeting HIV envelope elicit enhanced NK cell-mediated cytotoxicity against HIV-infected CD4+ T cell and macrophage targets

Journal of Leukocyte Biology

Morgane M. Brunton-O’Sullivan, Olaf G. Wilhelm, Christine Jordan, Hans Kek, Laura Rikard-Bell, Pantelis Poumbourios, Bruce D. Wines, Anthony Jaworowski, Anna C. Hearps, Hans Kek

Current projects

View 14 more
Methamphetamine and injecting drug use cohort studies: MIXMAX
Open to students

Methamphetamine and injecting drug use cohort studies: MIXMAX

MIXMAX is the largest active cohort study of people who use drugs in Australia. It combines 2 pre-existing studies: SuperMIX and VMAX.

Testing treatments for long COVID, a collaborative clinical trial

Testing treatments for long COVID, a collaborative clinical trial

HEAL APT: Harnessing effective approaches for long COVID therapies through an adaptive platform trial.

Immunotherapy-based approaches to cure HIV
Open to students

Immunotherapy-based approaches to cure HIV

The objectives of this project include identifying the relevant NK subset which is the most potent killer of HIV-infected cells and developing anti-HIV antibodies with enhanced function.

View 14 more

News and features

Advancing research through NHMRC grants and scholarships

Advancing research through NHMRC grants and scholarships

Meet the female powerhouses behind HIV research at Burnet

Meet the female powerhouses behind HIV research at Burnet

On this page